Vortex Biosciences Takes On Board Becton Dickinson Alumnus
Executive Summary
Net Scientific's portfolio company and circulating tumor cell capture specialist Vortex Biosciences adds to its board of directors Deborah Neff, ex-chief operating officer of Complete Genomics and a former BD executive.
You may also be interested in...
DEVICE DEBUTS: Product And New Indication Launches From Medtronic, Strkyer, Siemens, And More
This month's edition of Device Debuts includes new product launches from Medtronic, Cochlear, Qualcomm, Titan Spine, Stryker, Philips, Nuance, Nevro, Siemens, Vortex BioSciences, ResMed, Respircardia, and others.
Device Debuts: Medtronic, Boston Scientific, Philips, Seventh Sense, Vortex, 410 Medical
Device Debuts is a new regular feature highlighting Medtech Insight editors’ top picks of medical devices that have been commercialized for the first time in the last month. This edition features an innovative minimally invasive surgical stapler, a pain-free blood-collection device, a novel approach for collecting, and circulating tumor cells, a rapid fluid-infusion device for critically ill patients, and an EP-mapping and navigation system.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.